Pauleikhoff Daniel, Yu Siqing, Bachmeier Isabel, Armendariz Beatriz Garcia, Bormann Eike, Pauleikhoff Laurenz
Dep. of Ophthalmology, St. Franziskus Hospital, Hohenzollernring 74, 48155, Münster, Germany.
F. Hoffmann-La Roche Ltd, Pharma Research and Early Development, Basel, Switzerland.
Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):957-964. doi: 10.1007/s00417-024-06712-6. Epub 2024 Dec 22.
This retrospective, real-life cohort was analyzed to detect the frequency of different HRM evolution patterns and their correlation with MNV types, morphological and functional changes in exudative nAMD under long-term anti-VEGF therapy. We evaluated optical coherence tomography (OCT) volume scans in 143 eyes of 94 nAMD patients (start of anti-VEGF therapy 2009-2018, therapy until the last visit) and recorded the VA at all visits. HRM evolution patterns were differentiated: pattern 1 = no HRM, pattern 2 = subretinal HRM resolved during follow-up, pattern 3 = persistent subretinal HRM with new HRM-boundary remodeling [BR], pattern 4 = persistent subretinal HRM without HRM-BR. Pattern 1 was observed in 58 eyes (40.6%), 33 eyes (23.1%) showed pattern 2, 39 eyes (27.3%) pattern 3 and 13 eyes (9.1%) pattern 4. HRM pattern correlated with type 1-3 MNV (p = 0.02), especially pattern 1 with type 1 MNV and pattern 3 with type 2 MNV. Over time, a change of MNV types could be observed only from type 2 into type 1 MNV (p = 0.0001). Some eyes with HRM pattern 3 changed during follow-up into pattern 4, which was often associated with the presence of macular atrophy (p = 0.0001) and demonstrated a reduced mean VA compared to pattern 1-3 at baseline (p = 0.0001), year 1 (p = 0.0001) and final visit (p = 0.02).In this study, we characterized different HRM evolution patterns in a real-world dataset and demonstrated their associations with MNV transformation during long term anti-VEGF therapy. The HRM patterns may provide prognostic value with morphological and functional implications.
对这个回顾性的真实生活队列进行分析,以检测不同的高反射物质(HRM)演变模式的频率及其与地图状萎缩性新生血管性年龄相关性黄斑变性(nAMD)的脉络膜新生血管(MNV)类型、形态和功能变化在长期抗血管内皮生长因子(VEGF)治疗下的相关性。我们评估了94例nAMD患者的143只眼的光学相干断层扫描(OCT)容积扫描(抗VEGF治疗开始于2009年至2018年,治疗至最后一次就诊),并记录了所有就诊时的视力(VA)。HRM演变模式被区分如下:模式1 = 无HRM,模式2 = 视网膜下HRM在随访期间消退,模式3 = 持续性视网膜下HRM伴有新的HRM边界重塑[BR],模式4 = 持续性视网膜下HRM无HRM - BR。58只眼(40.6%)观察到模式1,33只眼(23.1%)显示模式2,39只眼(27.3%)模式3,13只眼(9.1%)模式4。HRM模式与1 - 3型MNV相关(p = 0.02),尤其是模式1与1型MNV,模式3与2型MNV。随着时间的推移,仅观察到MNV类型从2型转变为1型(p = 0.0001)。一些具有HRM模式3的眼在随访期间转变为模式4,这通常与黄斑萎缩的存在相关(p = 0.0001),并且与基线时模式1 - 3相比,在第1年(p = 0.0001)和最后一次就诊时(p = 0.02)平均视力降低。在本研究中,我们在一个真实世界的数据集中描述了不同的HRM演变模式,并证明了它们在长期抗VEGF治疗期间与MNV转变的关联。HRM模式可能具有形态学和功能学意义的预后价值。